Robert A. Freudenberg

Dresden, SN 01307, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.

177Lu-based radioligand therapy: A retrospective multicenter analysis to calculate the effective half-life and follow-up dose for the public.

Journal: Nuklearmedizin. Nuclear medicine

Published: January 29, 2026

Engineering of High-Yield Recombinant Adeno-Associated Virus Producer Plasmids.

Engineering of High-Yield Recombinant Adeno-Associated Virus Producer Plasmids.

Journal: Biotechnology journal

Published: July 30, 2025

Different 212Pb Generators and Its Radiation Safety Concerning 220Rn (Thoron) Emanation.

Different 212Pb Generators and Its Radiation Safety Concerning 220Rn (Thoron) Emanation.

Journal: Toxics

Published: March 25, 2025

[203/212Pb]Pb-VMT-α-NET as a novel theranostic agent for targeted alpha radiotherapy-first clinical experience.

[203/212Pb]Pb-VMT-α-NET as a novel theranostic agent for targeted alpha radiotherapy-first clinical experience.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 18, 2025

Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer Chromatography.

Comparison of ZnS(Ag) Scintillator and Proportional Counter Tube for Alpha Detection in Thin-Layer Chromatography.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 14, 2024

Gamma camera imaging characteristics of 203/212Pb as a theragnostic pair for targeted alpha therapy: a feasibility study.

Gamma camera imaging characteristics of 203/212Pb as a theragnostic pair for targeted alpha therapy: a feasibility study.

Journal: EJNMMI physics

Published: August 29, 2024

The heterobivalent (SSTR2/albumin) radioligand [67Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics.

The heterobivalent (SSTR2/albumin) radioligand [67Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics.

Journal: Theranostics

Published: June 25, 2024

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma.

Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma.

Journal: Journal of personalized medicine

Published: June 21, 2024

Scalability study on [133La]LaCl3 production with a focus on potential clinical applications.

Scalability study on [133La]LaCl3 production with a focus on potential clinical applications.

Journal: EJNMMI radiopharmacy and chemistry

Published: May 16, 2024

Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers-New Aspects and Revelations.

Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers-New Aspects and Revelations.

Journal: Pharmaceutics

Published: March 08, 2024

Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine

Evaluation of risk analysis in treatment with unsealed radioactive substances in nuclear medicine

Journal: Nuklearmedizin. Nuclear medicine

Published: January 23, 2024

Radiosynthesis of Stable 198Au-Nanoparticles by Neutron Activation of αvβ3-Specific AuNPs for Therapy of Tumor Angiogenesis.

Radiosynthesis of Stable 198Au-Nanoparticles by Neutron Activation of αvβ3-Specific AuNPs for Therapy of Tumor Angiogenesis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 06, 2023

Showing 1-12 of 58

Last Updated: 09/26/2026